| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |